Literature DB >> 8446845

Specificities of monoclonal antibodies to domain I of alpha-gliadins.

H J Ellis1, A P Doyle, H Wieser, R P Sturgess, P J Ciclitira.   

Abstract

Eight monoclonal antibodies were raised against a sequenced 54-amino-acid peptide of alpha-gliadin, which is thought to exacerbate coeliac disease. Five of the antibodies cross-reacted with coeliac non-toxic cereals. Two of eight of the antibodies bound specifically to coeliac toxic prolamins. These two antibodies cross-reacted with high molecular weight gliadins, which are closely related to alpha-gliadins and whose toxicity to patients with coeliac disease is unclear. The antibodies were screened by enzyme-linked immunosorbent assay against three amino-acid-sequenced peptides of alpha-gliadin with single amino-acid differences. Differential binding of antibody WC2 suggested that this antibody binds in the region of amino-acid residue 36, a proline residue, where there may be an antigenic beta-reverse turn. This proline residue forms part of a tetrapeptide motif, QQQP, which is thought to be present in all coeliac-active peptides.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8446845     DOI: 10.3109/00365529309096074

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  2 in total

1.  Measurement of gluten using a monoclonal antibody to a coeliac toxic peptide of A-gliadin.

Authors:  H J Ellis; S Rosen-Bronson; N O'Reilly; P J Ciclitira
Journal:  Gut       Date:  1998-08       Impact factor: 23.059

2.  Molecular biology of coeliac disease.

Authors:  R Tighe; P J Ciclitira
Journal:  Arch Dis Child       Date:  1995-09       Impact factor: 3.791

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.